SCHEMBL22926

SCHEMBL22926

CC(N)(CO)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22925 1.00
SCHEMBL161672 1.00
SCHEMBL28893505 1.00 GGT1 (0.50)
SCHEMBL28893506 1.00 GGT1 (0.50)
Water SCHEMBL29958098 0.97
Hydrochloric Acid SCHEMBL976478 0.97
Water SCHEMBL28938842 0.97
Hydrochloric Acid SCHEMBL976477 0.97
Water SCHEMBL978511 0.97
SCHEMBL30689470 0.79 GGT1 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3434 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4736944-A2 POLYPEPTIDES AND USES THEREOF MedImmune Limited (GB) 2026-05-06 EP claimed
EP-4679087-A1 BIOMARKER AND USE THEREOF MEIJI CO., LTD (JP) 2026-01-14 EP claimed
WO-2025109003-A1 P-CADHERIN LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2025-05-30 WO claimed
US-12122816-B2 Long acting peptide tyrosine tyrosine (PYY) analogs and methods of use I2O THERAPEUTICS, INC. (US) 2024-10-22 US claimed
WO-2024190663-A1 BIOMARKER AND USE THEREOF 株式会社明治 2024-09-19 WO claimed
US-20240293476-A1 Methods and Compositions for Changing Metabolite Levels in a Subject ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2024-09-05 US claimed
CN-118562905-A Method for preparing 2-methyl-L-serine by using enzymatic method 长兴制药股份有限公司 2024-08-30 CN claimed
CN-118510796-A Combinations of relaxin and vasopressin analogues for the treatment of renal disorders or conditions 瑞沃2肾脏公司 2024-08-16 CN claimed
EP-4392440-A2 COMBINATION OF RELAXIN AND VASOPRESSIN ANALOGUES FOR TREATMENT OF RENAL DISORDERS OR CONDITIONS River 2 Renal Corp. (US) 2024-07-03 EP claimed
US-20240166708-A1 LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE I2O THERAPEUTICS, INC. 2024-05-23 US claimed
CN-1036832-C Composition containing a penem or carbapenem artibiotic and the use of the same SANKYO CO (JP) 1997-12-31 CN claimed
EP-0413528-B1 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use YU RUEY J (US) 1995-11-15 EP claimed
US-5091171-A Skin disorders IGI, INC. 1992-02-25 US claimed
EP-0226304-B1 COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC SANKYO COMPANY LIMITED (JP) 1991-08-28 EP claimed
EP-0413528-A1 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use Yu, Ruey J., Dr. (US) 1991-02-20 EP claimed
US-4757066-A Reduces renal toxicity SANKYO COMPANY LIMITED (JP) 1988-07-12 US claimed
EP-0226304-A1 Composition containing a penem or carbapenem antibiotic SANKYO COMPANY LIMITED (JP) 1987-06-24 EP claimed
CN-86107574-A Compositions containing penem or carbapenem antibiotics and their use 1987-05-20 CN claimed
US-4043811-A POTASSIUM FERROCYANIDE, PHOSPHORIC ACID, BUFFER, TRIETHANOLAMINE ADDRESSOGRAPH MULTIGRAPH CORPORATION (US) 1977-08-23 US claimed
US-3998955-A 2-CARBOXY OR 2-ALKOXYCARBONYL-PYRIDINES CIBA-GEIGY CORPORATION (US) 1976-12-21 US claimed